Contributions of gene marking to cell and gene therapies.
The first human genetic modification studies used replication-incompetent integrating vector vectors to introduce marker genes into T lymphocytes and subsequently into hematopoietic stem cells. Such studies have provided numerous insights into the biology of hematopoiesis and immune reconstitution and contributed to clinical development of gene and cell therapies. Tracking of hematopoietic reconstitution and analysis of the origin of residual malignant disease after hematopoietic transplantation has been possible via gene marking. Introduction of selectable marker genes has enabled preselection of specific T-cell populations for tumor and viral immunotherapy and reduced the threat of graft-versus-host disease, improving the survival of patients after allogeneic marrow transplantation. Marking studies in humans, murine xenografts, and large animals have helped optimize conditions for gene transfer into CD34(+) hematopoietic progenitors, contributing to the achievement of gene transfer efficiencies sufficient for clinical benefit in several serious genetic diseases such as X-linked severe combined immunodeficiency and adrenoleukodystrophy. When adverse events linked to insertional mutagenesis arose in clinical gene therapy trials for inherited immunodeficiencies, additional animal studies using gene-marking vectors have greatly increased our understanding of genotoxicity. The knowledge gained from these studies is being translated into new vector designs and clinical protocols, which we hope will continue to improve the efficiency, effectiveness and safety of these promising therapeutic approaches.
Hematology Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20852, USA.
Cecilia N
CN
Barese
Cynthia E
CE
Dunbar
D000818:Animals; D018941:Antigens, CD19 / Q000235:genetics; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D005819:Genetic Markers; D015316:Genetic Therapy / Q000379:methods*; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000378:metabolism; D006801:Humans; D051379:Mice; D020800:Receptor, Nerve Growth Factor / Q000235:genetics; D013601:T-Lymphocytes / Q000276:immunology / Q000637:transplantation*
D018941:Antigens, CD19; D005819:Genetic Markers; D020800:Receptor, Nerve Growth Factor
Science. 2005 May 20;308(5725):1171-4
15905401
Blood. 1998 Sep 15;92(6):1878-86
9731044
Hum Gene Ther. 2008 Jul;19(7):699-709
18557699
Nature. 2010 Sep 16;467(7313):318-22
20844535
Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1457-62
16432223
Hum Gene Ther. 1992 Jun;3(3):305-18
1643150
J Immunol Methods. 2006 Mar 20;310(1-2):30-9
16516225
Blood. 2010 Feb 4;115(5):925-35
19880495
Blood. 2010 Apr 1;115(13):2610-8
20093403
N Engl J Med. 2009 Jan 29;360(5):447-58
19179314
Blood. 2003 Mar 15;101(6):2099-114
12511419
Science. 1997 Jun 13;276(5319):1719-24
9180086
Nat Med. 2006 Apr;12(4):401-9
16582916
Blood. 2009 Oct 22;114(17):3546-56
19652199
Mol Ther. 2007 Jul;15(7):1248-52
17505474
Lancet. 2004 Dec 18-31;364(9452):2181-7
15610804
Blood. 1994 May 15;83(10):3068-76
7514051
Blood. 2007 Jun 1;109(11):4698-707
17327416
Lancet. 1993 Jan 9;341(8837):85-6
8093407
Hum Gene Ther. 2007 Aug;18(8):691-700
17655493
Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11871-6
8876230
Mol Ther. 2008 Sep;16(9):1617-23
18578011
Nat Med. 1998 Oct;4(10):1201-5
9771757
Mol Ther. 2008 Mar;16(3):439-49
18227842
Blood. 2006 Oct 15;108(8):2545-53
16825499
Gene Ther. 1996 Feb;3(2):179-83
8867866
Stem Cells. 2001;19(2):118-24
11239166
Hum Gene Ther. 2009 Dec;20(12):1607-26
19689196
Blood. 2005 Feb 1;105(3):1010-5
15383461
Blood. 2004 Jun 1;103(11):4070-7
14962906
Leuk Lymphoma. 1999 Jan;32(3-4):279-88
10037025
Curr Opin Hematol. 2007 Jul;14(4):337-42
17534158
Science. 1991 Mar 15;251(4999):1363-6
1848369
Hum Gene Ther. 2009 Jun;20(6):563-72
19222366
Hum Gene Ther. 1999 Jul 20;10(11):1783-90
10446918
Nat Med. 2009 Dec;15(12):1431-6
19966782
J Clin Invest. 2008 Sep;118(9):3143-50
18688286
Mol Ther. 2000 May;1(5 Pt 1):448-56
10933966
Hum Gene Ther. 1998 Nov 20;9(17):2629-40
9853529
Science. 2009 Nov 6;326(5954):818-23
19892975
Mol Ther. 2006 Oct;14(4):505-13
16905365
Hum Gene Ther. 1997 Jul 20;8(11):1313-9
9295126
Blood. 2008 Sep 15;112(6):2278-86
18566328
Mol Ther. 2006 Jun;13(6):1031-49
16624621
Blood. 2009 Aug 13;114(7):1319-30
19414858
Nat Med. 1995 Oct;1(10):1017-23
7489356
Science. 2002 Jun 28;296(5577):2410-3
12089448
J Immunol. 2004 Sep 15;173(6):3620-30
15356106
Blood. 1999 Oct 1;94(7):2271-86
10498599
Blood. 1997 Jun 1;89(11):4040-6
9166843
Blood. 2002 Oct 15;100(8):2737-43
12351380
Bone Marrow Transplant. 2008 Jan;41(2):199-205
17994122
Blood. 2005 Jun 1;105(11):4255-7
15687233
Cancer Gene Ther. 2007 Mar;14(3):227-32
17082794
Biochem Biophys Res Commun. 1999 Jul 14;260(3):712-7
10403831
Mol Ther. 2009 Nov;17(11):1910-8
19638958
Hum Gene Ther. 2009 Sep;20(9):989-98
19485761
Immunol Rev. 1997 Jun;157:217-22
9255632
Hum Gene Ther. 1997 Mar 20;8(5):615-24
9095412
Blood. 1998 Aug 15;92(4):1131-41
9694700
Proc Natl Acad Sci U S A. 1997 Oct 28;94(22):12133-8
9342375
Blood. 1997 Sep 1;90(5):1777-86
9292510
Biol Blood Marrow Transplant. 2007 Aug;13(8):913-24
17640595
Gene Ther. 2002 Dec;9(23):1633-8
12424616
Curr Opin Immunol. 2009 Apr;21(2):233-40
19304471
N Engl J Med. 1990 Aug 30;323(9):570-8
2381442
Blood. 1992 Sep 1;80(5):1120-4
1325209
Blood. 1992 May 15;79(10):2694-700
1316784
Mol Ther. 2007 Feb;15(2):355-60
17235314
Lancet. 1993 Nov 6;342(8880):1134-7
7901474
Science. 2000 Apr 28;288(5466):669-72
10784449
Hum Gene Ther. 1998 May 20;9(8):1157-64
9625254
Nat Med. 1996 Aug;2(8):876-82
8705856
Blood. 2007 Sep 15;110(6):1806-13
17526860
Int J Hematol. 2001 Jan;73(1):14-22
11372750
Nat Biotechnol. 2006 Jun;24(6):687-96
16732270
Blood. 2004 Jun 1;103(11):4062-9
14976042
Gene Ther. 2010 Apr;17(4):511-20
20016542
Blood. 2009 May 28;113(22):5434-43
19339698
Hum Gene Ther. 2001 Apr 10;12(6):607-17
11426461
Curr Opin Mol Ther. 2002 Oct;4(5):482-90
12435050
Science. 2006 Oct 6;314(5796):126-9
16946036
J Clin Invest. 2009 Jul;119(7):1952-63
19509470
Cell. 1985 Aug;42(1):71-9
4016956
Mol Ther. 2008 Apr;16(4):718-25
18334985
Blood. 1998 Dec 15;92(12):4612-21
9845527
Lancet. 1995 Jan 7;345(8941):9-13
7799740
Blood. 1995 Jun 1;85(11):3048-57
7538814
Hum Gene Ther. 1996 Mar 20;7(5):655-67
8845391
Mol Ther. 2010 Apr;18(4):674-83
20104209
Science. 2003 Oct 17;302(5644):415-9
14564000
Hum Gene Ther. 2007 May;18(5):451-6
17536975
Blood. 2006 May 15;107(10):3865-7
16439674
J Clin Invest. 2010 Jul;120(7):2345-54
20551514
PLoS Biol. 2004 Aug;2(8):E234
15314653
Science. 2002 Apr 19;296(5567):497
11964471
Science. 1995 Oct 20;270(5235):475-80
7570001
Science. 1995 Oct 20;270(5235):470-5
7570000
Blood. 2005 Jun 1;105(11):4235-46
15713797
N Engl J Med. 2010 Nov 11;363(20):1918-27
21067383
Nat Med. 2003 Apr;9(4):367-9
12669036
Blood. 2004 Jan 15;103(2):492-9
14512305